Evaxion Biotech opens new office and laboratories to support future growth

COPENHAGEN: Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced the opening of its new corporate headquarters and research laboratory facility located in the DTU Science Park in Hoersholm near Copenhagen, Denmark. The new facility will unite Evaxion’s diverse research and corporate… Continue reading